Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North Africa

CompletedOBSERVATIONAL
Enrollment

449

Participants

Timeline

Start Date

January 21, 2015

Primary Completion Date

February 11, 2018

Study Completion Date

February 11, 2018

Conditions
Non-small Cell Lung Cancer
Trial Locations (11)

Unknown

National Cancer Institute, Cairo

National Cancer Institute, Cairo / Misr Al Qadimah

American University in Beirut, Beirut

American University of Beirut, Beirut

Institut National d'Oncologie, Rabat

King Abdulaziz Medical City - National Guard Hospital, Riyadh

King Faisal Specialty Hospital, Riyadh/Oncology Department, Riyadh

King Faisal Specialty Hospital, Riyadh

National Guard Hospital, Riyadh

Tawam Hospital, Al Ain City

Tawam Hospital, Al Ain/Al Maqam

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY